title: Galactose breath testing distinguishes variant and severe galactose-1-phosphate uridyltransferase genotypes.
abstract: A galactose breath test that quantitates [1-(13)C]galactose conversion to 13CO2 provides information on the whole body galactose oxidative capacity. As there is little information on the relationship between whole body oxidation and the genotype in patients with galactosemia, we measured the 13CO2 excretion for 2 h after administration of [1-(13)C]galactose in 37 patients (3-48 y old) with galactose-1-phosphate uridyltransferase (GALT) deficiency and 20 control subjects (3-37 y old). Eleven patients with the common Q188R/Q188R genotype and no detectable erythrocyte GALT activity eliminated <2% of a bolus of [1-(13)C]galactose as 13CO2 compared with 8.47 to 28.23% in controls. This defines a severe metabolic phenotype. Seven patients with one Q188R allele and a second mutant allele such as L195P, E308K, V151A, M142K, or Q344K and one patient with a K285N/unknown genotype also released <2% as 13CO2 in 2 h. The presence of N314D or S135L as the second mutant allele does not impair total body galactose oxidation, as individuals with the GALT genotype of Q188R/N314D, K285N/N314D, and Q188R/S135L had normal 2-h galactose breath tests. Subjects with S135L/S135L, N314D/N314D, S135L/deltaT2359 as well as other rarer genotypes such as R258C/Y209C, E203K/IVSC-N314D, K285N/T138M, Q188R/D113N, S135L/F171S, R148W/N314D, and IVSC-N314D/N314D oxidized galactose comparable to controls. The dissociation of residual erythrocyte GALT activity and whole body galactose oxidative capacity is exemplified by blacks with a S135L/S135L genotype and absent erythrocyte GALT activity. An oral 2-h [1-(13)C]galactose breath test distinguishes severe and variant GALT genotypes and enables delineation of the extent of impaired galactose metabolism in an array of patients who possess diverse GALT mutations. It may prove to be useful in establishing whether a patient is capable of manifesting disease similar to patients with a Q188R/Q188R genotype.
authors.affiliation: Department of Pediatrics, University of Pennsylvania School of Medicine, The Children's Hospital of Philadelphia, 19104, USA.
authors.forename: G T
authors.initials: GT
authors.lastname: Berry
authors.forename: R H
authors.initials: RH
authors.lastname: Singh
authors.forename: A T
authors.initials: AT
authors.lastname: Mazur
authors.forename: N
authors.initials: N
authors.lastname: Guerrero
authors.forename: M J
authors.initials: MJ
authors.lastname: Kennedy
authors.forename: J
authors.initials: J
authors.lastname: Chen
authors.forename: R
authors.initials: R
authors.lastname: Reynolds
authors.forename: M J
authors.initials: MJ
authors.lastname: Palmieri
authors.forename: P D
authors.initials: PD
authors.lastname: Klein
authors.forename: S
authors.initials: S
authors.lastname: Segal
authors.forename: L J
authors.initials: LJ
authors.lastname: Elsas
mesh_terms: D000293:Adolescent; D000328:Adult; D001944:Breath Tests; D002648:Child; D002675:Child, Preschool; D005260:Female; D005690:Galactose / Q000378:metabolism*; D014644:Genetic Variation; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation; D011237:Predictive Value of Tests; D005694:UTP-Hexose-1-Phosphate Uridylyltransferase / Q000235:genetics* / Q000378:metabolism*
chemical_list: D005694:UTP-Hexose-1-Phosphate Uridylyltransferase; D005690:Galactose